Unsolved:SKCPT
From HandWiki
SKCPT (SKI 306X) is a drug under development by SK Chemicals for the treatment of osteoarthritis. It is in a Phase III trial as of 2023.[1][2][3]
It is a purified extract from a mixture plants (Clematis mandshurica, Trichosanthes kirilowii, and Prunella vulgaris) which are each used in herbal medicine.[4]
References
- ↑ "Error: no
|title=specified when using {{Cite web}}". https://www.globaldata.com/store/report/skcpt-in-osteoarthritis-loa-innovation-and-trend-analysis/. - ↑ Kim, Hye-Min; Kang, Minseok; Jung, Yoon-Seok; Lee, Yoon-Jung; Choi, Wonjae; Yoo, Hunseung; Kim, JeongHoon; An, Hyo-Jin (January 2023). "Effects of SKCPT on Osteoarthritis in Beagle Meniscectomy and Cranial Cruciate Ligament Transection Models" (in en). International Journal of Molecular Sciences 24 (19): 14972. doi:10.3390/ijms241914972. ISSN 1422-0067. PMID 37834419.
- ↑ "SKCPT by SK Chemicals for Osteoarthritis: Likelihood of Approval". 31 July 2023. https://www.pharmaceutical-technology.com/data-insights/skcpt-sk-chemicals-osteoarthritis-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-229015&utm_campaign=recommended-articles.
- ↑ Jung, Young Bok; Roh, Kwon-Jae; Jung, Jin-A; Jung, Kiwon; Yoo, Hunseung; Cho, Yong-Baik; Kwak, Wie-Jong; Kim, Dae-Kee et al. (2001). "Effect of SKI 306X, a New Herbal Anti-Arthritic Agent, in Patients with Osteoarthritis of the Knee: A Double-Blind Placebo Controlled Study". The American Journal of Chinese Medicine 29 (3n04): 485–491. doi:10.1142/S0192415X01000502. PMID 11789591.
 |  |
